chr9-94558939-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_003837.4(FBP2):āc.1019A>Gā(p.Ter340TrpextTer3) variant causes a stop lost change. The variant allele was found at a frequency of 0.002 in 1,614,060 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.011 ( 30 hom., cov: 32)
Exomes š: 0.0011 ( 26 hom. )
Consequence
FBP2
NM_003837.4 stop_lost
NM_003837.4 stop_lost
Scores
3
4
Clinical Significance
Conservation
PhyloP100: 3.77
Genes affected
FBP2 (HGNC:3607): (fructose-bisphosphatase 2) This gene encodes a gluconeogenesis regulatory enzyme which catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Stoplost variant in NM_003837.4 Downstream stopcodon found after 64 codons.
BP6
Variant 9-94558939-T-C is Benign according to our data. Variant chr9-94558939-T-C is described in ClinVar as [Benign]. Clinvar id is 786143.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0108 (1646/152210) while in subpopulation AFR AF= 0.038 (1578/41530). AF 95% confidence interval is 0.0364. There are 30 homozygotes in gnomad4. There are 785 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1646 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBP2 | NM_003837.4 | c.1019A>G | p.Ter340TrpextTer3 | stop_lost | 7/7 | ENST00000375337.4 | |
PCAT7 | NR_121566.2 | n.357T>C | non_coding_transcript_exon_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBP2 | ENST00000375337.4 | c.1019A>G | p.Ter340TrpextTer3 | stop_lost | 7/7 | 1 | NM_003837.4 | P1 | |
PCAT7 | ENST00000647389.1 | n.258-30T>C | intron_variant, non_coding_transcript_variant | ||||||
PCAT7 | ENST00000452148.3 | n.258-30T>C | intron_variant, non_coding_transcript_variant | 2 | |||||
PCAT7 | ENST00000644721.1 | n.264-30T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0108 AC: 1646AN: 152092Hom.: 30 Cov.: 32
GnomAD3 genomes
AF:
AC:
1646
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00273 AC: 687AN: 251416Hom.: 12 AF XY: 0.00204 AC XY: 277AN XY: 135888
GnomAD3 exomes
AF:
AC:
687
AN:
251416
Hom.:
AF XY:
AC XY:
277
AN XY:
135888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00108 AC: 1584AN: 1461850Hom.: 26 Cov.: 31 AF XY: 0.000935 AC XY: 680AN XY: 727232
GnomAD4 exome
AF:
AC:
1584
AN:
1461850
Hom.:
Cov.:
31
AF XY:
AC XY:
680
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0108 AC: 1646AN: 152210Hom.: 30 Cov.: 32 AF XY: 0.0105 AC XY: 785AN XY: 74414
GnomAD4 genome
AF:
AC:
1646
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
785
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
152
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
437
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at